Research and Development

Showing 15 posts of 9599 posts found.

GSK paves way for biopharmaceuticals growth

September 9, 2010 Research and Development GlaxoSmithKline, Lonza, biologics

GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …

Universities attack European research grant

September 9, 2010 Research and Development EFPIA, IMI, Innovative Medicines Initiative, academia

A European initiative aimed at fostering new medical research is neglecting its public partners in favour of its private ones, …

EU set to pass stricter laws for experiments on animals

September 9, 2010 Research and Development Animal testing, Animal tests

The number of animals used in scientific experiments will be reduced under new EU legislation agreed by the European Parliament …

Tzvi Palash joins Protalix BioTherapeutics

September 9, 2010 Manufacturing and Production, Research and Development Portalix BioTherapeutics, appointment, manufacturing and production, research and development

Protalix BioTherapeutics has appointed Tzvi Palash to the newly-created position of chief operating officer. He will be responsible for overseeing …
Andreotti

BMS to acquire ZymoGenetics

September 8, 2010 Research and Development, Sales and Marketing BMS, hepatitis

 Bristol-Myers Squibb is to acquire biopharma company ZymoGenetics for $885 million to add to its ‘string of pearls’of small biotech …
Dr Meena Jain

Working Life: Dr Meena Jain

September 8, 2010 Business Services, Research and Development Napp, Working Life, careers, recruitment

How did you find your way into your most current role? I’ve been at Napp for four years now having …

GSK patient recruitment head joins Exco InTouch

September 8, 2010 Research and Development Exco InTouch, appointment, research and development

Judith Teall has been appointed director of patient recruitment at clinical trial technology company Exco InTouch. She has spent more …

Pfizer drops brain cancer vaccine

September 7, 2010 Research and Development Celldex Therapeutics, Pfizer, cancer vaccine

Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …

Roche signs Alzheimer’s deal with reMYND

September 7, 2010 Research and Development Alzheimer's, Parkinson's, Roche, reMYND

Roche has signed a deal with Belgian biotech reMYND to develop new treatments for patients with Alzheimer’s and Parkinson’s disease. …

Merck averts day in court over Dutch plant closure

September 7, 2010 Manufacturing and Production, Research and Development Merck & Co, Netherlands, job cuts

Merck & Co has postponed the planned closure of the former Organon facility in Oss, the Netherlands, after weeks of …

Next generation Malaria drug shows promise

September 6, 2010 Research and Development malaria

A Novartis-led collaboration has discovered a novel anti-malarial candidate that could become the first new treatment for the disease in …

Pradaxa, Xarelto and apixaban vie for attention

September 6, 2010 Research and Development, Sales and Marketing Pradaxa, Xarelto, apixaban, atrial fibrilation

New data has intensified the competition between three rival would-be cardiology blockbusters. Boehringer Ingelheim’s Pradaxa (dabigatran) and Bayer’s Xarelto (rivaroxaban) …
Roche building

Roche set for jobs cuts from 2011

September 3, 2010 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, job cuts

Roche has confirmed it will take wide-ranging steps to reduce costs, following local reports the Swiss pharma firm was poised …

UK biotech body elects new chairman

September 3, 2010 Research and Development BIA, appointment, research and development

Cellzome’s president and chief executive Tim Edwards has been elected chairman of the BioIndustry Association. Commenting on his election he …

Contract research news in brief

September 3, 2010 Research and Development Cyprotex, Epistem, INC Research, Jubilant, Laxal Pharma

A round-up of recent news from the CRO sector, featuring updates from Cyprotex, INC Research, Laxai Pharma, Asuragen, Jubilant Organosys …
The Gateway to Local Adoption Series

Latest content